Journey Medical Corporation DERM Debt issuance costs and discount amortization
Debt issuance costs and discount amortization at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's debt issuance costs and discount amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's debt issuance costs and discount amortization?
- Journey Medical Corporation (DERM) reported debt issuance costs and discount amortization of $96K in Q1 2026.
- How has Journey Medical Corporation's debt issuance costs and discount amortization changed year-over-year?
- Journey Medical Corporation's debt issuance costs and discount amortization decreased by 5.0% year-over-year, from $101K to $96K.
- What is the long-term trend for Journey Medical Corporation's debt issuance costs and discount amortization?
- Over 3 years (2022 to 2025), Journey Medical Corporation's debt issuance costs and discount amortization has grown at a 94.8% compound annual growth rate (CAGR), from $63K to $466K.
- What does debt issuance costs and discount amortization mean?
- This represents the non-cash periodic charge recognized to amortize debt issuance costs or original issue discounts over the life of a debt instrument. It reflects the gradual adjustment of the carrying value of debt toward its face value, impacting non-cash operating expenses. Investors monitor this to understand the effective interest expense incurred beyond stated coupon payments.